Top Markets
Coin of the day
PlexBio Co., Ltd. PlexBio Co., Ltd.

PlexBio Co., Ltd.

6572
Rank in Stocks #28557
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Share Price
$0.24898639
Last synced: 2026-08-19
Market Cap
$25.81M
Change (1 day)
8.00%
Change (1 year)
-21.43%
Country
TW
Trade PlexBio Co., Ltd. (6572)

Category

Earnings for PlexBio Co., Ltd. (6572)
Earnings in 2026 TTM: 0
According to PlexBio Co., Ltd. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for PlexBio Co., Ltd. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH